Risk factors for cancer development in Helicobacter pylori gastritis.

GAPIO Nardone - Digestive and Liver Disease, 2000 - iris.unina.it
Despite the progressive decline in incidence in the last 50 years, gastric cancer continues to
be the most frequent neoplasia in Asia and some Latin American countries, and is the …

Tetrahydrofurandiol Stimulation of Phospholipase A2, Lipoxygenase, and Cyclooxygenase Gene Expression and MCF-7 Human Breast Cancer Cell Proliferation

BM Markaverich, J Crowley, M Rodriquez… - Environmental …, 2007 - ehp.niehs.nih.gov
Background We characterized an endocrine disruptor from ground corncob bedding
material that interferes with male and female sexual behavior and ovarian cyclicity in rats …

面两亲性分子改造的铂类脂质体的分泌性磷脂酶A2响应性和体外抗肿瘤活性

刘燕娇, 文成, 李丹, 高佩, 朱国东 - 中国药科大学学报, 2022 - jcpu.cpu.edu.cn
铂类脂质体在肿瘤部位的定点药物释放是其发挥疗效的关键, 本研究以二棕榈酰磷脂酰胆碱和二
硬脂酰磷脂酰乙醇胺-聚乙二醇2k 两种磷脂为基础, 构建带有面两亲性分子石胆酸(lithocholic …

[PDF][PDF] Estrogen, phospholipase A and breast cancer

W Thomas, F Caiazza, BJ Harvey - Front Biosci, 2008 - academia.edu
[Frontiers in Bioscience 13, 2604-2613, January 1, 2008] 2604 Estrogen, phospholipase A and
breast cancer Warren Thomas, France Page 1 [Frontiers in Bioscience 13, 2604-2613 …

Synergistic Effects of Secretory Phospholipase A2 from the Venom of Agkistrodon piscivorus piscivorus with Cancer Chemotherapeutic Agents

J Nelson, K Barlow, DO Beck, A Berbert… - BioMed Research …, 2013 - Wiley Online Library
Healthy cells typically resist hydrolysis catalyzed by snake venom secretory phospholipase
A2. However, during various forms of programmed cell death, they become vulnerable to …

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer

JN Mock, JP Taliaferro, X Lu, SK Patel… - Bioorganic & medicinal …, 2012 - Elsevier
Haloenol pyran-2-ones and morpholin-2-ones were synthesized and evaluated as inhibitors
of cell growth in two different prostate human cancer cell lines (PC-3 and LNCaP). Analogs …

Cell biologic factors and cancer spread

J Yamashita, M Ogawa - International journal of …, 1997 - spandidos-publications.com
There is an increasing body of literature linking expression of cell biologic factors such as
proteases and bioactive peptides with tumor malignancy. Cancer cells and/or the …

Synthesis of lipids for development of multifunctional lipid-based drug-carriers

G Zhu, Y Alhamhoom, BS Cummings… - Bioorganic & medicinal …, 2011 - Elsevier
A simple approach to synthesize phospholipids to modulate drug release and track lipid-
based particulate drug-carriers is described. We synthesized two ether lipids, 1 1-O …

Liposomal drug release using ultrasound and modeling release dynamics for model predictive controller design

HG Moussa - 2015 - dspace.aus.edu
Chemotherapy is widely used for cancer treatment; however, it causes unwanted side effects
in patients such as fatigue, weight loss, pain, hair fall and nausea. Those side effects are …

Surgical trauma induces group II phospholipase A2 production by neutrophils at a local site after surgery

T Abe, K Sakamoto, S Mita, H Kamohara, Y Hirano… - Clinical …, 1998 - Elsevier
Objectives: Group II phospholipase A2 (PLA2) regulates eicosanoids and platelet activating
factor (PAF) production and plays an important role in regulating critical mediators in …